Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-020042-94-AT
EUCTR2010-020042-94-AT
Active, not recruiting
Phase 1

The Effect of High-dose Remifentanil on the Reversal of Neuropathic Pain in Postherpetic Patients - RemiHighDose PHZ

Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin0 sites21 target enrollmentJuly 27, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsRemifentanil

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin
Enrollment
21
Status
Active, not recruiting
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 27, 2010
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin

Eligibility Criteria

Inclusion Criteria

  • •Patients suffering from PHN.
  • •Pain \= 4 out of 10 in numeric rating scale (NRS)
  • •Female and male patients above the age of 18
  • •Ability to understand/write/read german
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Any of the following will exclude a subject from the study:
  • •Zoster affecting trigeminal\-, opticus region
  • •Any somatic pain which is stronger than the neuropathic pain
  • •Severe progressive disease
  • •Acute cardiac decompensation
  • •Known cardiac valve dysfunction
  • •Known pulmonary hypertension
  • •Cardiac conduction disturbance
  • •Active herpetic lesion
  • •Analgesic or antitussive opioid therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
The effect of high-dose remifentanil on the reversal of established capsaicin-induced hyperalgesia in human volunteersThis is a volunteer study in healthy volunteers. Pain research, reversal of hyperalgesia by IMP ist studied
EUCTR2009-011599-31-ATAbteilung für Anaesthesie und Intensivmedizin, Medizinische Universität Wien
Active, not recruiting
Not Applicable
The effect of high dose remifentanil on the reversal of established sunburn-induced hyperalgesia in human volunteers - High-Dose-RemiSuVolunteer study with 24 healthy volunteers to perform pain research and to study the reversal of hyperalgesia by IMP
EUCTR2009-015780-14-ATAbteilung für Anästhesie und Intensivmedizin, Medizinische Universität Wien
Completed
Not Applicable
Suppressive effects of high-dose remifentanil on stress response of patients during cardiac surgery with cardiopulmonary bypassPatients scheduled for elective cardiac surgery with CPB
JPRN-UMIN000012213Department of Anesthesiology, Kanazawa University Hospital20
Completed
Not Applicable
Effects of remifentanil concentrations on maximum mouth opening under general anesthesiaadult patients under general anesthesia
JPRN-UMIN000014187Kumamoto Kinoh Hospital200
Active, not recruiting
Not Applicable
The effect of remifentanil on the reversal of established sunburn-induced hyperalgesia in human volunteers.This is a volunteer study in healthy volunteers. Pain research, reversal of hyperalgesia by IMP is studied
EUCTR2008-008475-34-ATAbteilung für Anaesthesie und Intensivmedizin, Medizinische Universität Wien